Papsmeer and Colposcopy Findings in HPV Positive Patients

Document Type : Original Article(s)

Authors

1 Associated Professor, Department of Obstetrics and Gynecology, School of Medicine, Sharekord University of Medical Sciences, Shahrekord, Iran

2 Resident of Obstetrics and Gynecology, Department of Gynecology, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran

Abstract

Background: The present study aimed to determine colposcopy and histopathology findings in HPV positive patients as High Real tech done.
Methods: In this cross-sectional study, 100 HPV-positive women referred to the oncology clinic of Shahrekord University of Medical Sciences in 2021-2022, who had previously undergone a Pap smear test, underwent colposcopy, and the frequency of cervical lesions detected by the two mentioned methods was determined and the degree of agreement between the two methods was evaluated.
Findings: Out of 100 HPV positive patients, both pap smear and colposcopy findings were normal in 34 (34%) patients and both pap smear and colposcopy findings were abnormal in 35 (35%) patients. On the other hand, in 17 patients (17%) Pap smear findings were abnormal but colposcopy findings were normal. Also, in 14 patients (14%), pap smear findings were normal, but colposcopy findings were abnormal. According to the Kappa test, the agreement between pap smear and colposcopy in the diagnosis of normal and abnormal lesions was 0.38, which was statistically significant (P < 0.001).
Conclusion: The findings of the present study showed that there is an acceptable level of agreement between pap smear and colposcopy in the diagnosis of cervical lesions in HPV positive patients. On the other hand, detection of high-grade lesions is more likely with colposcopy.

Highlights

Setareh Fatehi: Google Scholar, PubMed

Sepideh Salehi: Google Scholar, PubMed

Keywords

Main Subjects

References

  1. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000; 19(1-2): 1-5.
  2. Alani RM, Münger K. Human papillomaviruses and associated malignancies. J Clin Oncol 1998; 16(1): 330-7.
  3. Munoz N, Castellsagué X, de González AB, Gissmann L. HPV in the etiology of human cancer. Vaccine 2006; 24(Suppl 3): S1-S10.
  4. Mortazavi S, Zali M, Raoufi M, Nadji M, Kowsarian P, Nowroozi A. The prevalence of human papillomavirus in cervical cancer in Iran. Asian Pac J Cancer Prev 2002; 3(1): 69-72.
  5. Beachler DC, Jenkins G, Safaeian M, Kreimer AR, Wentzensen N. Natural acquired immunity against subsequent genital human papillomavirus infection: a systematic review and meta-analysis. J Infect Dis 2016; 213(9): 1444-54.
  6. Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ. HPV‐mediated cervical carcinogenesis: concepts and clinical implications. J Pathol 2006; 208(2): 152-64.
  7. Jemal A, Simard E, Dorell C. Annual report to the nation on the status of cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 2013; 105(9): 175-201.
  8. Findik S, Findik S, Abuoğlu S, Cihan FG, Ilter H, Iyisoy MS. Human papillomavirus (HPV) subtypes and their relationships with cervical smear results in cervical cancer screening: a community-based study from the central Anatolia region of Turkey. Int J Clin Exp Pathol 2019; 12(4): 1391-8.
  9. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007; 370(9590): 890-907.
  10. Behnamfar F, Khamehchian T, Shishehgar M. Diagnostic value of colposcopy for identifying precancerous lesions of cervix in patients with abnormal pap smear [in Persian]. Feyz 2004; 8(2): 200-24.
  11. Matsuura Y, Kawagoe T, Toki N, Sugihara K, Kashimura M. Early cervical neoplasia confirmed by conization. Acta Cytol 1996; 40(2): 241-6.
  12. Karimi-Zarchi M, Zanbagh L, Shafii A, Taghipour-Zahir S, Teimoori S, Yazdian-Anari P. Comparison of pap smear and colposcopy in screening for cervical cancer in patients with secondary immunodeficiency. Electronic Physician 2015; 7(7): 1542-8.
  13. Chao S, McCaffrey RM, Todd WD, Moore JG. Conization in evaluation and management of cervical neoplasia. Am J Obstet Gynecol 1969; 103(4): 574-84.
  14. Nishimura A, Sugimori H, Tsukamoto N, Kashimura M, Taki I. Discrepancy between diagnoses by cytology and directed punch biopsy and final diagnoses in cervical borderline lesions. J Jpn Soc Clin Cytol 1976; 15(2): 123-30.
  15. Nkwabong E, Laure Bessi Badjan I, Sando Z. Pap smear accuracy for the diagnosis of cervical precancerous lesions. Trop Doct 2019; 49(1): 34-9.
  16. Karimi-Zarchi M, Zanbagh L, Shafii A, Taghipour-Zahir S, Teimoori S, Yazdian-Anari P. Comparison of pap smear and colposcopy in screening for cervical cancer in patients with secondary immunodeficiency. Electron Physician 2015; 7(7): 1542-8.
  17. Creasman WT, Rutledge F. Carcinoma in situ of the cervix an analysis of 861 patients. Obstet Gynecol 1972; 39(3): 373-80.
  18. Selim MA, So-Bosita JL, Blair OM, Little BA. Cervical biopsy versus conization. Obstet Gynecol 1973; 41(2): 177-82.
  19. Yalcin I, Sari M, Sahin H, Gultekin M, Gungor T, Meydanli M. Colposcopic biopsy findings among women with either HPV-16 only or HPV-18 only who have normal cervical cytology. Int J Gynaecol Obstet 2018 143(3): 300-5.
  20. Zaal A, Louwers J, Berkhof J, Kocken M, ter Harmsel W, Graziosi G, et al. Agreement between colposcopic impression and histological diagnosis among human papillomavirus type 16-positive women: a clinical trial using dynamic spectral imaging colposcopy. BJOG 2012; 37(119): 537-44.
  21. Moscicki A-B, Broering J, Powell K, Klein J, Clayton L, Smith G, et al. Comparison between colposcopic, cytologic, and histologic findings in women positive an negative for, human papillomavirus DNA. J Adolesc Health 1993; 14(2): 74-9.
Journal of Isfahan Medical School
Volume 43, Issue 814
2nd Week, July
July and August 2025
Pages 463-469

Files

History

  • Receive Date: 11 August 2024
  • Accept Date: 08 January 2025

Share

How to cite

Statistics